Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Dietary links to Alzheimer's disease: 1999 update.

Grant WB.

J Alzheimers Dis. 1999 Nov;1(4-5):197-201.

PMID:
12214118
3.

Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows.

Praticò D.

Ann N Y Acad Sci. 2008 Dec;1147:70-8. doi: 10.1196/annals.1427.010. Review.

PMID:
19076432
4.

Antioxidants and Alzheimer's disease: from bench to bedside (and back again).

Rutten BP, Steinbusch HW, Korr H, Schmitz C.

Curr Opin Clin Nutr Metab Care. 2002 Nov;5(6):645-51. Review.

PMID:
12394639
5.

Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.

Praticò D.

Trends Pharmacol Sci. 2008 Dec;29(12):609-15. doi: 10.1016/j.tips.2008.09.001. Epub 2008 Oct 4. Review.

PMID:
18838179
6.

Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).

Sultana R, Perluigi M, Butterfield DA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Mar 20;833(1):3-11. Epub 2005 Oct 17. Review.

PMID:
16236561
7.

Pathophysiology of neuronal energy crisis in Alzheimer's disease.

de la Torre JC.

Neurodegener Dis. 2008;5(3-4):126-32. doi: 10.1159/000113681. Epub 2008 Mar 6. Review.

PMID:
18322369
8.

Environmental and dietary risk factors in Alzheimer's disease.

Dosunmu R, Wu J, Basha MR, Zawia NH.

Expert Rev Neurother. 2007 Jul;7(7):887-900. Review.

PMID:
17610395
9.

A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.

Arendash GW, Jensen MT, Salem N Jr, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H.

Neuroscience. 2007 Oct 26;149(2):286-302. Epub 2007 Aug 14.

PMID:
17904756
11.

Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease.

Veurink G, Fuller SJ, Atwood CS, Martins RN.

Ann Hum Biol. 2003 Nov-Dec;30(6):639-67. Review.

PMID:
14675907
12.
13.

Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.

Liang X, Wang Q, Hand T, Wu L, Breyer RM, Montine TJ, Andreasson K.

J Neurosci. 2005 Nov 2;25(44):10180-7.

15.

Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.

Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, Carlson DA, Münch G.

Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1463-70. doi: 10.1016/j.addr.2008.04.015. Epub 2008 Jul 4. Review.

PMID:
18655815
16.

Cardiovascular risk factors for Alzheimer's disease.

Rosendorff C, Beeri MS, Silverman JM.

Am J Geriatr Cardiol. 2007 May-Jun;16(3):143-9. Review.

PMID:
17483665
17.

IANA task force on nutrition and cognitive decline with aging.

Gillette Guyonnet S, Abellan Van Kan G, Andrieu S, Barberger Gateau P, Berr C, Bonnefoy M, Dartigues JF, de Groot L, Ferry M, Galan P, Hercberg S, Jeandel C, Morris MC, Nourhashemi F, Payette H, Poulain JP, Portet F, Roussel AM, Ritz P, Rolland Y, Vellas B.

J Nutr Health Aging. 2007 Mar-Apr;11(2):132-52. Review.

PMID:
17435956
19.

Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.

Yamagishi S, Nakamura K, Matsui T, Inoue H, Takeuchi M.

Med Hypotheses. 2007;69(3):666-8. Epub 2007 Feb 28.

PMID:
17331665
20.

Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.

Feng Z, Qin C, Chang Y, Zhang JT.

Free Radic Biol Med. 2006 Jan 1;40(1):101-9. Epub 2005 Sep 7.

PMID:
16337883

Supplemental Content

Support Center